We are live on
!
Find out more
WL
WIT LLC Portfolio holdings
AUM
$5.3B
1-Year Est. Return
20.46%
This Fund
S&P 500
This Quarter
Est. Return
+5.8%
1 Year Est. Return
+20.46%
3 Year Est. Return
+33.94%
5 Year Est. Return
+15.77%
10 Year Est. Return
–
AUM
$2.6B
AUM Growth
-$854M
(-25%)
Cap. Flow
-$995K
Cap. Flow
% of AUM
-0.04%
Top 10 Holdings %
Top 10 Hldgs %
98.7%
Holding
17
New
3
Increased
2
Reduced
8
Closed
–
Top Buys
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$132K |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$29.4K |
| 3 |
Madrigal Pharmaceuticals
MDGL
|
+$6.13K |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$3.34K |
| 5 |
CrowdStrike
CRWD
|
+$419 |
Top Sells
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$906K |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$137K |
| 3 |
Vanguard Small-Cap ETF
VB
|
+$72.3K |
| 4 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$30.3K |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$15.9K |
Sector Composition
| 1 | Healthcare | 0.31% |
| 2 | Technology | 0.03% |
Similar funds
DRZID
CBUSF
SCM
FMWA
DPL
KKRC
SDIC
CCA
WIT LLC's Q4 2023 Portfolio in Review
As of Q4 2023, WIT LLC held 17 positions worth $2.6B, down 25% from $3.45B the previous quarter. Its ten largest holdings account for 99% of the portfolio.
WIT LLC's Q4 2023 filing shows 3 new, 2 increased and 8 reduced positions. Its largest new stake was Madrigal Pharmaceuticals: 35 shares worth $8.16M. The largest sale was Vanguard Short-Term Treasury ETF, an estimated $906K.
By sector, the portfolio is most concentrated in Healthcare at 0.31% of assets, followed by Technology.
- WIT LLC's largest Q4 2023 buy was Madrigal Pharmaceuticals: 35 shares worth $8.16M.
- WIT LLC added most to Vanguard FTSE Emerging Markets ETF in Q4 2023, an estimated $132K increase.
- WIT LLC's biggest Q4 2023 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $906K.
- WIT LLC's ten largest holdings make up 99% of its $2.6B portfolio in Q4 2023.
- WIT LLC opened 3 new positions and closed 0 in Q4 2023.
- WIT LLC's portfolio value fell 25% quarter-over-quarter to $2.6B.
Based on WIT LLC's 13F filing for Q4 2023, filed 14 Feb 2024.